GENEVA, July 6 -- BEIJING HUIDA CELL TECHNOLOGY CO., LTD filed a patent application (CN2025/145153) for “T CELL ANTIGEN RECEPTOR, LMP2-SPECIFIC T CELL, AND USE THEREOF”. With publication no. WO/2026/138882, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 14/725
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....